Evidence map›Paper›PMID 19465554›Full record

Trial reportAmerican journal of physiology. Heart and circulatory physiology2009

Carbon monoxide, skeletal muscle oxidative stress, and mitochondrial biogenesis in humans.

Michael A Rhodes, Martha Sue Carraway, Claude A Piantadosi, Crystal M Reynolds, Anne D Cherry, T E Wester, Michael J Natoli, E Wayne Massey, Richard E Moon, Hagir B Suliman

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of physiology. Heart and circulatory physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03799874 phase2completednot on this mapstarted 2019, after this paper: background citation

A Phase II Trial of Inhaled Carbon Monoxide for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

TypeinterventionalSponsorBrigham and Women's HospitalRan2019 to 2021Enrolled4ConditionsAcute Respiratory Distress SyndromeArmsInhaled Carbon Monoxide at 200 ppm, Inhaled Medical air
NCT04870125 phase1terminatednot on this mapstarted 2023, after this paper: background citation

A Phase Ib Trial of Inhaled Carbon Monoxide for the Treatment of Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)

TypeinterventionalSponsorBrigham and Women's HospitalRan2023 to 2024Enrolled5ConditionsAcute Respiratory Distress Syndrome, SepsisArmsInhaled Carbon Monoxide at CFK equation-determined personalized dose (200-500 ppm to achieve a COHb level of 6-8%), Inhaled Medical air
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Survival in critical illness is associated with early activation of mitochondrial biogenesis.American journal of respiratory and critical care medicine · 2010
    Trial
  4. Heme Metabolism-Derived Carbon Monoxide Regulates Skeletal Muscle Function.Journal of cachexia, sarcopenia and muscle · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Molecules (Basel, Switzerland) · 2021
    Article
  17. Carbon Monoxide: from Poison to Clinical Trials.Trends in pharmacological sciences · 2021
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Michael A RhodesDepartment of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.
Martha Sue Carraway
Claude A Piantadosi
Crystal M Reynolds
Anne D Cherry
T E Wester
Michael J Natoli
E Wayne Massey
Richard E Moon
Hagir B Suliman
Duke University Hospital · US

Funding

Regulation of mitochondrial biogenesis by heme oxygenase-1R01HL090679 · NHLBI · DUKE UNIVERSITY · PI PIANTADOSI, CLAUDE A · 2008 to 2011
$1.6M
NHLBI NIH HHS 1R01-HL-090679NHLBI NIH HHS R01 HL090679
6 · The paper itself

Abstract

Given that the physiology of heme oxygenase-1 (HO-1) encompasses mitochondrial biogenesis, we tested the hypothesis that the HO-1 product, carbon monoxide (CO), activates mitochondrial biogenesis in skeletal muscle and enhances maximal oxygen uptake (Vo(2max)) in humans. In 10 healthy subjects, we biopsied the vastus lateralis and performed Vo(2max) tests followed by blinded randomization to air or CO breathing (1 h/day at 100 parts/million for 5 days), a contralateral muscle biopsy on day 5, and repeat Vo(2max) testing on day 8. Six independent subjects underwent CO breathing and two muscle biopsies without exercise testing. Molecular studies were performed by real-time RT-PCR, Western blot analysis, and immunochemistry. After Vo(2max) testing plus CO breathing, significant increases were found in mRNA levels for nuclear respiratory factor-1, peroxisome proliferator-activated receptor-gamma coactivator-1alpha, mitochondrial transcription factor-A (Tfam), and DNA polymerase gamma (Polgamma) with no change in mitochondrial DNA (mtDNA) copy number or Vo(2max). Levels of myosin heavy chain I and nuclear-encoded HO-1, superoxide dismutase-2, citrate synthase, mitofusin-1 and -2, and mitochondrial-encoded cytochrome oxidase subunit-I (COX-I) and ATPase-6 proteins increased significantly. None of these responses were reproduced by Vo(2max) testing alone, whereas CO alone increased Tfam and Polgamma mRNA, and COX-I, ATPase-6, mitofusin-2, HO-1, and superoxide dismutase protein. These findings provide evidence linking the HO/CO response involved in mitochondrial biogenesis in rodents to skeletal muscle in humans through a set of responses involving regulation of the mtDNA transcriptosome and mitochondrial fusion proteins autonomously of changes in exercise capacity.

Indexed as

AdultAnaerobic ThresholdAntioxidantsBlotting, WesternCarbon MonoxideCarboxyhemoglobinDNA, MitochondrialDouble-Blind MethodFemaleGene DosageHumansMaleMicroscopy, FluorescenceMitochondria, MuscleMuscle, SkeletalMyosin Heavy ChainsAntioxidantsCarbon MonoxideCarboxyhemoglobinDNA, MitochondrialMyosin Heavy ChainsRNA

Identifiers

PMID19465554
PMCPMC2711725
OpenAlexW2153212778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.